TOPICAL FORMULATIONS FOR TREATING DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESS

(19)

(11)

EP 3 977 983 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	15.01.2025 Bulletin 2025/03

(45)	Mention of the grant of the patent:
	11.12.2024 Bulletin 2024/50

(21)	Application number: 21188525.6

(22)	Date of filing: 26.10.2018

(51)

International Patent Classification (IPC):

A61K 9/06^(2006.01)
A61K 47/08^(2006.01)
A61K 47/14^(2017.01)
A61K 47/32^(2006.01)
A61K 31/58^(2006.01)
A61K 8/55^(2006.01)
A61K 8/894^(2006.01)
A61K 8/14^(2006.01)

A61K 9/00^(2006.01)
A61K 47/10^(2017.01)
A61K 47/24^(2006.01)
A61K 9/127^(2006.01)
A61Q 7/00^(2006.01)
A61K 8/63^(2006.01)
A61K 31/473^(2006.01)
A61K 8/81^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61K 9/0014; A61K 47/08; A61K 47/10; A61K 47/14; A61K 47/24; A61K 9/06; A61K 47/32; A61K 9/127; A61K 31/473; A61Q 7/00; A61K 8/14; A61K 8/553; A61K 8/8152; A61K 8/63; A61K 8/894

(54)

TOPICAL FORMULATIONS FOR TREATING DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESS

TOPISCHE FORMULIERUNGEN ZUR BEHANDLUNG VON DERMATOLOGISCHEN STÖRUNGEN, EINSCHLIESSLICH MÄNNLICHER KAHLKÖPFIGKEIT

FORMULATIONS TOPIQUES DESTINÉES AU TRAITEMENT D'AFFECTIONS DERMATOLOGIQUES COMPRENANT LA CALVITIE HIPPOCRATIQUE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

27.10.2017 US 201762577869 P

(43)	Date of publication of application:
	06.04.2022 Bulletin 2022/14

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	18801196.9 / 3700506

(73)	Proprietor: XYON Health Inc.
	Vancouver, BC V5Y 1G3 (CA)

(72)	Inventors:
	HASSON, Victor Vancouver, BC V6H 4B1 (CA) CASTIGLIONE, Mauro Vancouver, BC V6H 4B1 (CA)

(74)	Representative: J A Kemp LLP
	80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)

(56)

References cited: :

CN-A- 106 361 703

US-A1- 2010 080 768

HYEONGMIN KIM ET AL: "Combined Skin Moisturization of Liposomal Serine Incorporated in Hydrogels Prepared with Carbopol ETD 2020, Rhesperse RM 100 and Hyaluronic Acid", KOREAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, vol. 19, no. 6, 1 November 2015 (2015-11-01), KR, pages 543 - 547, XP055372126, ISSN: 1226-4512, DOI: 10.4196/kjpp.2015.19.6.543

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).